Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer
- Conditions
- Spread Through Air SpaceNon-small Cell Lung CancerVisceral Pleural InvasionLymphovascular Invasion
- Registration Number
- NCT05925738
- Lead Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Brief Summary
The purpose of this study is to evaluate the performance of a PET/ CT-based deep learning signature for predicting aggressive histological pattern in resected non-small cell lung cancer based on a multicenter prospective cohort.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1500
(1) Participants scheduled for surgery for radiological finding of pulmonary lesions from the preoperative thin-section CT scans; (2) Pathological confirmation of primary NSCLC; (3) Age ranging from 20-75 years; (4) Obtained written informed consent.
(1) Multiple lung lesions; (2) Poor quality of PET-CT images; (3) Participants with incomplete clinical information; (4) Participants who have received neoadjuvant therapy.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Area under the receiver operating characteristic curve 2023.5.1-2023.10.31 The area under the receiver operating characteristic curve (ROC) of the deep learning model in predicting the presence or absence of the aggressive histological pattern. The aggressive histological pattern includes spread through air space (STAS), visceral pleural invasion (VPI), and lymphovascular invasion (LVI). And the model will output all predictive values (presence or absence) of the three kinds of aggressive histological patterns.
- Secondary Outcome Measures
Name Time Method Sensitivity 2023.5.1-2023.10.31 The sensitivity of the deep learning model in predicting the presence or absence of the aggressive histological pattern. The aggressive histological pattern includes spread through air space (STAS), visceral pleural invasion (VPI), and lymphovascular invasion (LVI). And the model will output all predictive values (presence or absence) of the three kinds of aggressive histological patterns.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (3)
Affiliated Hospital of Zunyi Medical University
🇨🇳Zunyi, Guizhou, China
The First Affiliated Hospital of Nanchang University
🇨🇳Nanchang, Jiangxi, China
Ningbo HwaMei Hospital
🇨🇳Ningbo, Zhejiang, China
Affiliated Hospital of Zunyi Medical University🇨🇳Zunyi, Guizhou, China